17.03.2011 • NewsJames O'BrienAshlandPeople

James O'Brien to Have Colon Surgery

Ashland head James OBrien is expected to be out for two to three months...
Ashland head James O'Brien is expected to be out for two to three months following colon surgery.

Specialty chemicals company Ashland on Wednesday said Chairman and Chief Executive James O'Brien will have surgery to fix a perforated colon and be out for two to three months.

The company said he would be available on "a limited basis" until his full return.

Lead director Barry Perry will be interim chairman, while CFO Lamar Chambers and general counsel David Hausrath will assume his executive duties, Ashland said.

Separately, the company said it would repurchase $400 million in shares and that it intends to raise its annual dividend to 70 cents per share from 60 cents per share, beginning with the June 15 dividend payment.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.